I
Infusion Express
The iv therapy you need in a place and time that works for you
About Infusion Express
IVX Health, formerly known as Infusion Express, specializes in providing high-quality infusion and injection therapy services for patients with chronic conditions. The company operates in the healthcare market, focusing on patients who require ongoing infusion treatments. IVX Health offers private patient suites equipped with leather recliners, flat-screen TVs, high-speed Wi-Fi, and complimentary snacks, ensuring a comfortable and private experience for its clients. The business model revolves around partnering with healthcare providers to deliver these services in a more convenient and patient-friendly setting compared to traditional hospital environments. IVX Health generates revenue through service fees charged for each infusion session, often covered by insurance plans. The company serves a diverse clientele, including individuals with autoimmune diseases, neurological conditions, and other chronic illnesses requiring regular infusion therapy. By prioritizing patient comfort and convenience, IVX Health aims to redefine the infusion care experience.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Brentwood, United States
- Employees
- 578
- Open positions
- None listed
- Dealroom signal
- 54.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Retail, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Oct 2017 | $14M | $54M | McKesson Ventures | — |
Growth signals
Latest recorded traffic for Infusion Express is 0 monthly website visits. Infusion Express's team grew 17.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
McKesson Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Infusion Express on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Infusion Express’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







